CTU: A Phase 2 Open-label Extension Study for Subjects with Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

  • Gurney, Howard (Primary Chief Investigator)
  • Chester, Catherine (Clinical Trial Unit Staff)
  • Chapman, Nicola (Clinical Trial Unit Staff)

Project: Research

Project Details

Short title9785-CL-0123
Acronym9785-CL-0123
StatusActive
Effective start/end date6/07/22 → 20/03/27